IPTA 2025 - Mobis

P1.1 The spectrum of post-transplant diabetes mellitus in children in a tertiary care hospital in India

Dr. Indira Agarwal, India

P1.2 Bridging the gap: Navigating donor-recipient size mismatch in pediatric renal transplants

Alanoud Alshami, Saudi Arabia

P1.3 Novel biomarkers predictive for graft dysfunction – a pilot study using machine learning prediction as an AI tool

Mrs. Andreea-Liana Bot Rachisan, Romania

P1.5 Infectious Complications on Low and High dose Novel Induction Regimens After Pediatric Kidney Transplantation

Dr. Jayanthi Chandar, United States

P1.6 Clinicopathological Features Associated with Allograft Failure in FSGS Recurrence

Dr. Olga Charnaya, United States

P1.7 Optimal pediatric timing for kidney transplant in lupus nephritis: a survey study

Abanti Chaudhuri, United States

P1.8 Renal Cell Carcinoma in a Pediatric Kidney Transplant Recipient

Dr. Heeyeon Cho, Korea

P1.9 Pediatric vs. Adult Living Donor Kidney Transplantation: A Comparative Analysis from a High-Volume Tertiary Center

Dr. Devprakash Choudhary, India

P1.10 Is there a difference in outcome between DCD and DBD donor kidneys in pediatric transplant recipients? A nationwide analysis

Dr. Huib De Jong, Netherlands

P1.11 Contemporary treatment responses of recurrent focal segmental glomerulosclerosis or steroid resistant nephrotic syndrome in children after kidney transplantation: Phase 2 of a multicenter electronic health record data analysis

Dr. Vikas Dharnidharka, United States

P1.12 Application of MC4R Agonist Setmelanotide in two post-renal transplant patients with Bardet-Biedl Syndrome (BBS): Successful Reduction in Hyperphagia and BMI

Dr. Ilja Finkelberg, Germany

P1.13 Pediatric to adult transition: Analysis of a standardized assessment protocol for kidney transplant patients

Jon Garrison, United States

P1.14 Outcomes of paediatric kidney transplant: A single centre experience from Sri Lanka

Dr. Vindya N Gunasekara Sr., Sri Lanka

P1.15 The first cohort of paediatric kidney transplant recipients with hostile bladder in Sri Lanka

Dr. Vindya N Gunasekara Sr., Sri Lanka

P1.16 Development of non-human leukocyte antigens antibodies and their association with antibody-mediated rejection in pediatric kidney transplant recipients

Nele Kanzelmeyer, Germany

P1.17 Prevalence and Associations of Nephrocalcinosis in Pediatric Kidney Transplant Recipients

Dr. Stella Kilduff, United States

P1.18 Long-term outcomes of kidney transplantation in pediatric patients with CAKUT and Non-CAKUT

Mr. Lin Lang, People's Republic of China

P1.19 Incidence and risk factors associated with gastrointestinal (GI) manifestations following pediatric kidney transplant

Dr. Daniella Levy Erez, Israel

P1.20 Spatial transcriptomics in paediatric kidney transplant rejection

Dr. Barian Mohidin, United Kingdom

P1.21 Filtration fraction is higher in children post-kidney transplantation and associates with lower serum creatinine

Dr. Barian Mohidin, United Kingdom

P1.21a (P1.30 in journal) Transition processes for adolescent kidney transplant recipients to adult care

Prof. Stephen D Marks, United Kingdom

P1.22 Positive impact on graft function with repeated courses of Bortezomib in antibody-mediated rejection in a pediatric renal transplant recipient

Dr. Lucy McAvoy, United Kingdom

P1.23 Long term outcomes of sirolimus based immunosuppression among haplotyped-matched pediatric living donor kidney transplant recipients

Mrs. JoAnn M Morey, United States

P1.23a Financial burden of kidney transplantation

Mrs. JoAnn M Morey, United States

P1.24 Evaluating Recurrent Glomerulonephritis in Kidney Transplantation

Dr. Rupesh Raina, United States

P1.25 Low incidence of rejection and de novo donor-specific antibody formation following covid-19 vaccination or infection among pediatric kidney transplant recipients

Helen Pizzo, United States

P1.26 Phenotypic expansion of CRB2-related disease in monozygotic twins with multisystem involvement and severe post-transplant complications: Case report and literature review

Dr. Moran Plonsky Toder, Israel

P1.27 Cardiovascular profile of children with end-stage kidney disease prior to living donor kidney transplantation

Dr. Henny A Puspitasari, Indonesia

P1.28 Prevalence and risk factors for pseudotumor cerebri syndrome in pediatric kidney transplant patients

Dr. Sandra Amaral, United States

P1.29 Outcomes and challenges in paediatric kidney transplantation in small recipients: a 20-year retrospective study

Dr. Thozama V Siyotula, South Africa

P1.31 Long-Term Outcomes of Pediatric Kidney Transplantation: A Single-Center Retrospective Study of 710 Cases

Miss Yi Feng, People's Republic of China

P1.32 Retrospective study of nephronophthisis after renal transplantation in our center

Ms. Ayuko Zaitsu, Japan